Effect of requiring advance approval of chemotherapy on number and cost of ungiven doses.

Berhoune, Malik; Aboudagga, Haïl; Jacob, Aude; Grandhaye, Jean-Pierre; Dayot, Corinne; Prognon, Patrice; Bonan, Brigitte

Berhoune, Malik; Aboudagga, Haïl; Jacob, Aude; Grandhaye, Jean-Pierre; Dayot, Corinne; Prognon, Patrice; Bonan, Brigitte.

Am J Health Syst Pharm ; 68(7): 557-8, 2011 Apr 01.

Article in En | MEDLINE | ID: mdl-21411796

Subject(s)

Antineoplastic Agents/economics; Drug Compounding/economics; Pharmacy Service, Hospital/economics; Pharmacy Service, Hospital/legislation & jurisprudence; Antineoplastic Agents/administration & dosage; Costs and Cost Analysis; Drug Compounding/standards; France; Humans; Pharmacy Service, Hospital/standards

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacy Service, Hospital / Drug Compounding / Antineoplastic Agents Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Am J Health Syst Pharm Journal subject: FARMACIA / HOSPITAIS Year: 2011 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google